Quarterly Insider Transactions at Apellis Pharmaceuticals, Inc. (APLS)
Shares Bought
Shares Sold
APLS Insider transactions
| Quarter | Buy / Adquisition | Sell / Disposition | Net Activity | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Traded Shares | Avg. Price /p share | Transactions | Insiders | Traded Shares | Avg. Price /p share | Transactions | Insiders | |||
| Q4 2024 | — | 182K | $0.0 $0 | 1 | 1 | (182K) | ||||
| Q3 2024 | 20.4K | $9.01 $183,601 | 3 | 3 | 48.3K | $29.72 $1.44 Million | 5 | 3 | (27.9K) | |
| Q2 2024 | 193K | $6.89 $1.33 Million | 7 | 3 | 203K | $41.73 $8.48 Million | 9 | 3 | (10.1K) | |
| Q1 2024 | 602K | $1.7 $1.02 Million | 21 | 16 | 469K | $64.43 $30.2 Million | 57 | 12 | 134K | |
| Q4 2023 | 232K | $8.05 $1.87 Million | 10 | 7 | 227K | $53.09 $12.1 Million | 19 | 11 | 4.81K | |
| Q3 2023 | 628K | $4.91 $3.08 Million | 13 | 6 | 378K | $54.34 $20.5 Million | 17 | 8 | 250K | |
| Q2 2023 | 1.42M | $5.63 $8.01 Million | 24 | 7 | 1.36M | $60.1 $82 Million | 31 | 8 | 59K | |
| Q1 2023 | 815K | $2.05 $1.67 Million | 43 | 17 | 155K | $54.74 $8.51 Million | 60 | 15 | 660K | |
| Q4 2022 | 121K | $5.11 $618,464 | 11 | 4 | 102K | $51.6 $5.26 Million | 22 | 10 | 19.1K | |
| Q3 2022 | 186K | $11.07 $2.06 Million | 22 | 5 | 178K | $60.91 $10.8 Million | 24 | 7 | 8.25K | |
| Q2 2022 | 112K | $7.97 $891,556 | 13 | 5 | 131K | $31.92 $4.19 Million | 30 | 14 | (19.5K) | |
| Q1 2022 | 449K | $3.58 $1.61 Million | 32 | 18 | 45.4K | $42.84 $1.94 Million | 35 | 13 | 403K | |
| Q4 2021 | 289K | $9.11 $2.63 Million | 12 | 7 | 24.4K | $42.08 $1.03 Million | 14 | 4 | 264K | |
| Q3 2021 | 42.9K | $6.39 $273,823 | 11 | 8 | 10K | $63.21 $632,100 | 9 | 4 | 32.9K | |
| Q2 2021 | 167K | $5.41 $902,175 | 22 | 8 | 237K | $51.01 $12.1 Million | 28 | 7 | (70.2K) | |
| Q1 2021 | 282K | $1.38 $390,453 | 38 | 13 | 38.5K | $48.66 $1.87 Million | 24 | 10 | 244K | |
| Q4 2020 | 125K | $7.54 $942,599 | 13 | 8 | 130K | $46.89 $6.1 Million | 26 | 7 | (5.11K) | |
| Q4 2017 | 5.77M | $14.0 $80.7 Million | 3 | 2 | — | 5.77M | ||||